These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin]. Acar N, Diri MC, Türkyilmaz FR. Mikrobiyol Bul; 1987 Oct; 21(4):284-8. PubMed ID: 3332705 [Abstract] [Full Text] [Related]
23. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase]. Moittie D, Simonet M, Veron M. Pathol Biol (Paris); 1989 May; 37(5):390-3. PubMed ID: 2789362 [Abstract] [Full Text] [Related]
26. In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or amdinocillin against bacteria isolated from patients with complicated urinary tract infections. Naber KG, Wittenberger R. Rev Infect Dis; 1986 Apr; 8 Suppl 5():S604-8. PubMed ID: 3026011 [Abstract] [Full Text] [Related]
27. An evaluation of susceptibility testing methods for ampicillin-sulbactam using a panel of beta-lactamase-producing bacteria. Siu LK, Lo JY, Cheng WL, Ho PL, Ng WS, Chau PY. APMIS; 1999 Jul; 107(7):703-8. PubMed ID: 10440070 [Abstract] [Full Text] [Related]
30. Inactivation of beta-lactamases by sulbactam and enhanced clinical activity due to target-site binding of the combination of sulbactam and ampicillin. Yokota T. APMIS Suppl; 1989 Jul; 5():9-16. PubMed ID: 2786726 [Abstract] [Full Text] [Related]
32. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains. Paniagua GL, Monroy E, García O, Vaca S. Rev Latinoam Microbiol; 1998 Jul; 40(3-4):128-34. PubMed ID: 10932741 [Abstract] [Full Text] [Related]
33. Selection of variants of the TEM-1 beta-lactamase, encoded by a plasmid of clinical origin, with increased resistance to beta-lactamase inhibitors. Thomson CJ, Amyes SG. J Antimicrob Chemother; 1993 May; 31(5):655-64. PubMed ID: 8392995 [Abstract] [Full Text] [Related]
34. A multicentre study to evaluate the effect of sulbactam/ampicillin combination on anaerobic micro-organisms. Leone F, Morandotti MG, Mazzella P, Sanna A, Ravizzola G, Colombrita D, Pinzi G, Turano R, Menozzi MG, Lecchini R. J Int Med Res; 1990 May; 18(3):191-200. PubMed ID: 2193834 [Abstract] [Full Text] [Related]
35. Beta-lactamase inhibition by acetylmethylene penicillanic acid compared to that of clavulanate and sulbactam. Chin NX, McElrath MJ, Neu HC. Chemotherapy; 1988 May; 34(4):318-25. PubMed ID: 2850139 [Abstract] [Full Text] [Related]
39. CTX-M-190, a Novel β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia coli Clinical Isolate. Shen Z, Ding B, Bi Y, Wu S, Xu S, Xu X, Guo Q, Wang M. Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821452 [Abstract] [Full Text] [Related]